Ushbu ish iqtibos qilgan ishlar

28 ta ish

Ish: Novel Covalent FAP-Targeted [ ⁶⁸ Ga]Ga-DOTA-mFS-KERERG-FAP-2286 for Improved Pharmacokinetics and Enhanced Tumor Uptake

1. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading

   Oleg Trott, Arthur J. Olson

   MaqolaOAOchiq kirish200939 iqtibos

   ABIABI:AkademIndex/2026.other.083068

2. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings

   Jérôme Eberhardt, Diogo Santos‐Martins, Andreas F. Tillack +1

   Maqola202117 iqtibos

   ABIABI:AkademIndex/2026.other.252828

3. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein

   Thomas Lindner, Anastasia Loktev, Annette Altmann +6

   MaqolaOAOchiq kirish20183 iqtibos

   ABIABI:AkademIndex/2026.other.144639

4. ⁶⁸Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer

   Clemens Kratochwil, Paul Flechsig, Thomas Lindner +15

   Maqola20193 iqtibos

   ABIABI:AkademIndex/2026.other.340319

5. Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

   Richard P. Baum, Christiane Schuchardt, Aviral Singh +12

   Maqola20213 iqtibos

   ABIABI:AkademIndex/2026.other.340321

6. Extended Structure–Activity Relationship and Pharmacokinetic Investigation of (4-Quinolinoyl)glycyl-2-cyanopyrrolidine Inhibitors of Fibroblast Activation Protein (FAP)

   Koen Jansen, Leen Heirbaut, Robert Verkerk +8

   Maqola20142 iqtibos

   ABIABI:AkademIndex/2026.other.144626

7. Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy

   Mengxin Xu, Pu Zhang, Jie Ding +3

   MaqolaOAOchiq kirish20212 iqtibos

   ABIABI:AkademIndex/2026.other.144649

8. Synthesis and Preclinical Evaluation of a Novel FAPI-04 Dimer for Cancer Theranostics

   Xuan Zhong, Jingru Guo, Xiuping Han +4

   Maqola20232 iqtibos

   ABIABI:AkademIndex/2026.other.144655

9. LigPlot+: Multiple Ligand–Protein Interaction Diagrams for Drug Discovery

   Roman A. Laskowski, Mark B. Swindells

   Maqola20112 iqtibos

   ABIABI:AkademIndex/2026.other.561669

10. Trends in peptide drug discovery

    Markus Muttenthaler, Glenn F. King, David J. Adams +1

    Sharh maqola20212 iqtibos

    ABIABI:AkademIndex/2026.other.802988

11. Understanding fibroblast activation protein (FAP): Substrates, activities, expression and targeting for cancer therapy

    Elizabeth Hamson, Fiona M. Keane, Stefan Tholen +2

    Sharh maqola20142 iqtibos

    ABIABI:AkademIndex/2026.other.838566

12. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.879159

13. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.879162

14. Sarlavhasiz

    Boshqa2 iqtibos

    ABIABI:AkademIndex/2026.other.879167

15. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879154

16. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879155

17. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879156

18. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879157

19. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879158

20. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879160

21. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879161

22. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879163

23. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879164

24. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879165

25. Sarlavhasiz

    Boshqa1 iqtibos

    ABIABI:AkademIndex/2026.other.879166